In brief, the variation of the ApoB/ApoA1 ratio arising from the progress of CHB disease is worth studying, and it can indirectly suggest the effect exerted by the progress of CHB disease on atherosclerosis, and add novel insights for the early diagnosis of LC and HCC. The gene discussed is APOA1; the disease is hepatocellular carcinoma.